Advances made by ETC company could lead to less drug testing on animals

Five years ago Alex Zhavoronkov didn’t see anything wrong with animal testing. Now the work his company does could lead to less animals being used to test medicine and cosmetics.Insilico Medicine is using advances in deep learning and artificial intelligence to change the way drugs are taken from inception to trial. Zhavronokov, Insilico’s CEO, says the R&D programs in the pharmaceutical industry have been on the decline. Fewer drugs are making it out of trials because of the way testing is done. Alex Zhavoronkov. (Photo via LinkedIn) “There are just a few dozen drugs that are approved every year. Basically one of the reasons why there is such a decline in research and development is because animal testing is not very representative of what the human outcome will be,” he…


Link to Full Article: Advances made by ETC company could lead to less drug testing on animals